Inhibition of β-amyloid formation by haloperidol: A possible mechanism for reduced frequency of Alzheimer's disease pathology in schizophrenia

Journal of Neurochemistry

Volumn 68, Issue 1, 1997, Pages 333-336

  Higaki, Jeffrey ^a   Murphy Jr , Greer M ^b   Cordell, Barbara ^a  

^a SCIOS INC   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Amyloid; Haloperidol; Schizophrenia

Indexed keywords

HALOPERIDOL; PROTEINASE;

AGED; ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; PROTEINASE INHIBITION; SCHIZOPHRENIA;

ANIMALIA;

EID: 0031018057     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.68010333.x     Document Type: Article

References (16)

1. Arnold S.E. and Trojanowski J. Q. (1996) Cognitive impairment in elderly schizophrenia: a dementia (still) lacking distinctive histopathology. Schizophr. Bull. 22, 5-9.
2. Arnold S. E., Franz B. R., and Trojanowski J. Q. (1994) Elderly patients with schizophrenia exhibit infrequent neurodegenerative lesions. Neurobiol. Aging 15, 299-303.
3. Arnold S. E., Gur R. E., Shapiro R. M., Fisher K. R., Moberg P. J., Gibney M. R., Gur R. C., Blackwell P., and Trojanowski J. Q. (1995) Prospective clinicopathologic studies of schizophrenia: accrual and assessment of patients. Am. J. Psychiatry 152, 731-737.
4. Bore J. J., Larson D. B., Lyons J. S., and Beardsley R. S. (1991) Expenditures for psychotropic medications in the United States in 1985. Am. J. Psychiatry 148, 644-647.
5. Casanova M. F., Carosella N. W., Gold J. M., Kleinman J. E., Weinberger D. R., and Powers R. E. (1993) A topographical study of senile plaques and neurofibrillary tangles in the hippocampi of patients with Alzheimer's disease and cognitively impaired patients with schizophrenia. Psychiatry Res. 49, 41-62.
6. DesJarlais R. L., Seibel G. L., Kuntz I. D., Furth P. S., Alvarez J. C., Ortiz de Montellano P. R., DeCamp D. L., Babe L. M., and Craik C. S. (1990) Structure-based design of nonpeptide inhibitors specific for the human immunodeficiency virus 1 protease. Proc. Natl. Acad. Sci. USA 87, 6644-6648.
7. Goldberg T. E., Hyde T. M., Kleinman J. E., and Weinberger D. R. (1993) Course of schizophrenia: neuropsychological evidence for a static encephalopathy. Schizophr. Bull. 4, 797-804.
8. Heaton R., Paulsen J. S., McAdams L. A., Kuck J., Zisoock S., Braff D., Harris J., and Jesste D. V. (1994) Neuropsychological deficits in schizophrenia. Relationship to age, chronicity, and dementia. Arch. Gen. Psychiatry 51, 469-476.
9. Higaki J., Quon D., Zhong Z., and Cordell B. (1995) Inhibition of β-amyloid formation identifies proteolytic precursors and subcellular site of catabolism. Neuron 14, 651-659.
10. Jarrett J. Y. and Landsbury P. T. (1993) Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73, 1055-1058.
11. Powchik P., Davidson M., Nemeroff C. B., Haroutunian V., Purohit D., Losonczy M., Bissette G., Perl D., Ghanbari H., Miller B., and Davis K. L. (1993) Alzheimer's disease-related protein in geriatric schizophrenic patients with cognitive impairment. Am. J. Psychiatry 150, 1726-1727.
12. Prohovnik I., Dwork A., Kaufman M. A., and Wilson N. (1993) β-Amyloid Alzheimer-type neuropathology in elderly schizophrenia patients. Schizophr. Bull. 4, 805-816.
13. Purohit D. P., Davidson M., Perl D. P., Haroutunian V. H., Bierer L. M., McCrystal J., Losonczy M. F., and Davis K. L. (1993) Severe cognitive impairment in elderly schizophrenic patients: a clinicopathological study. Biol. Psychiatry 33, 255-260.
14. Soustek Z. (1989) Ultrastructure of cortical synapses in the brain of schizophrenics. Zentralbl. Allg. Pathol. 135, 25-32.
15. Tsuneizumi T., Babb S. M., and Cohen B. M. (1992) Drug distribution between blood and brain as a determinant of antipsychotic drug effects. Biol. Psychiatry 32, 817-824.
16. Wisniewski H., Constantinidis J., Wegiel J., Bobinski J., and Tarnawski M. (1994) Neurofibrillary pathology in brains of elderly schizophrenics treated with neuroleptics. Alzheimer Dis. Assoc. Disord. 8, 211-227.